Strekin AG

With their summer vacations behind them, three biopharmaceutical companies returned from the long Labor Day weekend in the US with big funding announcements – Achilles Therapeutics Ltd. , NKarta The

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c

There are no therapies currently available for hearing loss that protect or restore hearing, Decibel Therapeutics ' CEO Steven Holtzman told Scrip, describing the area as a "white space." The con

In the second quarter, start-up biopharmas raised $1.63bn, an increase over the $1.34bn raised in the first quarter of 2016, but well down from the impressive $2.47bn raised back in Q2 2015. New and e